Lululemon Shares Dropped After the Company Cut Its Annual Forecast. Is the Stock a Buy Amid the Selloff?

The core issue is not a one-quarter miss; it’s a demand-quality problem in the largest profit pool. U.S. weakness at a premium price point suggests the brand has lost some elasticity advantage, so margin pressure is likely to persist even if units stabilize, because the fix requires either heavier promotional spend or product re-merchandising that compresses full-price sell-through. The China growth story is real, but it is not yet large enough to offset U.S. deleveraging, and international mix shift may actually lift reported growth while masking a lower-quality earnings base.

The second-order risk is that management’s reset window extends into the new CEO handoff, which creates a “no accountability” gap for the next two quarters. That matters because any operational fix typically needs at least one full product cycle to show up, so the stock can remain a lagging indicator well into autumn even if sentiment stabilizes. The proxy-fight settlement removes a headline overhang, but it also removes a convenient scapegoat; once the founder noise fades, investors will focus directly on whether product innovation and brand heat are actually improving.

The market may still be underestimating how little room a premium athletic brand has to maneuver when traffic softens: tariffs, freight, and labor inflation are all working against a company that cannot meaningfully discount without damaging long-term brand equity. If the company’s 15% assortment reduction improves productivity, that’s a 2026 story, not a near-term earnings catalyst. Near term, any bounce is likely to be driven more by short-covering and oversold conditions than by fundamental revisions.

The contrarian view is that the setup could become investable only if the stock over-discounts a cyclical reset and the new CEO is given a credible operating runway. But without evidence of same-store sales inflection in the U.S., the risk/reward remains asymmetric to the downside because earnings revisions are still drifting lower. In other words, the market is not just pricing a bad quarter; it is starting to price a multi-quarter brand recovery cycle.